| Joseph J Casella, DO | |
|
272 Us Highway 206, Andover, NJ 07821-3950 | |
| (973) 347-2273 | |
| (973) 729-3238 |
| Full Name | Joseph J Casella |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 43 Years |
| Location | 272 Us Highway 206, Andover, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891781514 | NPI | - | NPPES |
| 1572105 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 25MB04068700 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Atlantic Home Care & Hospice | Morristown, NJ | Home health agency |
| Compassionate Care Hospice Of Northern Nj Llc | Sparta, NJ | Hospice |
| Newton Medical Center | Newton, NJ | Hospital |
| Morristown Medical Center | Morristown, NJ | Hospital |
| Hackettstown Medical Center | Hackettstown, NJ | Hospital |
| Saint Clare's Hospital/ Denville Campus | Denville, NJ | Hospital |
| Limecrest Subacute And Rehabilitation Center | Andover, NJ | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Premier Health Associates Llc | 0840283008 | 35 |
News Archive
Kessler Foundation researchers published results of their TBI-MEM trial, the first study to demonstrate significant changes in cerebral activation after memory retraining in individuals with traumatic brain injury.
Scientists of the University of Freiburg and the Freiburg University Medical Center from the collaborative research center Medical Epigenetics (SFB 992) have discovered a new active substance that inhibits cell division in leukemia cells and could play an important role in the fight against cancer.
Today, the U.S. Food and Drug Administration granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent or advanced endometrial cancer that has progressed on or following prior treatment with a platinum-containing chemotherapy and whose cancers have a specific genetic feature known as dMMR (which contain abnormalities that affect the proper repair of DNA inside the cell), as determined by an FDA-approved test.
The EU Commission has launched a study on the economic and technical evolution of the scientific publication markets in Europe, the results of which will be available in 2005. The objective is to determine the conditions required for optimum operation of the sector and to assess the extent to which the Commission can help to meet those conditions.
› Verified 6 days ago
| Entity Name | Premier Health Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043257991 PECOS PAC ID: 0840283008 Enrollment ID: O20041209000067 |
News Archive
Kessler Foundation researchers published results of their TBI-MEM trial, the first study to demonstrate significant changes in cerebral activation after memory retraining in individuals with traumatic brain injury.
Scientists of the University of Freiburg and the Freiburg University Medical Center from the collaborative research center Medical Epigenetics (SFB 992) have discovered a new active substance that inhibits cell division in leukemia cells and could play an important role in the fight against cancer.
Today, the U.S. Food and Drug Administration granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent or advanced endometrial cancer that has progressed on or following prior treatment with a platinum-containing chemotherapy and whose cancers have a specific genetic feature known as dMMR (which contain abnormalities that affect the proper repair of DNA inside the cell), as determined by an FDA-approved test.
The EU Commission has launched a study on the economic and technical evolution of the scientific publication markets in Europe, the results of which will be available in 2005. The objective is to determine the conditions required for optimum operation of the sector and to assess the extent to which the Commission can help to meet those conditions.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph J Casella, DO 532 Lafayette Rd, Suite 300, Sparta, NJ 07871-4411 Ph: (973) 940-0423 | Joseph J Casella, DO 272 Us Highway 206, Andover, NJ 07821-3950 Ph: (973) 347-2273 |
News Archive
Kessler Foundation researchers published results of their TBI-MEM trial, the first study to demonstrate significant changes in cerebral activation after memory retraining in individuals with traumatic brain injury.
Scientists of the University of Freiburg and the Freiburg University Medical Center from the collaborative research center Medical Epigenetics (SFB 992) have discovered a new active substance that inhibits cell division in leukemia cells and could play an important role in the fight against cancer.
Today, the U.S. Food and Drug Administration granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent or advanced endometrial cancer that has progressed on or following prior treatment with a platinum-containing chemotherapy and whose cancers have a specific genetic feature known as dMMR (which contain abnormalities that affect the proper repair of DNA inside the cell), as determined by an FDA-approved test.
The EU Commission has launched a study on the economic and technical evolution of the scientific publication markets in Europe, the results of which will be available in 2005. The objective is to determine the conditions required for optimum operation of the sector and to assess the extent to which the Commission can help to meet those conditions.
› Verified 6 days ago
Dr. Melissa Lynn Reilly, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 272 Route 206 North, Andover, NJ 07821 Phone: 973-347-2273 Fax: 973-347-3238 | |
Ms. Catherine R Trader, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Lenape Road, Andover, NJ 07821 Phone: 973-786-0235 Fax: 973-786-0315 |